These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32277476)

  • 1. A Bayes factor approach with informative prior for rare genetic variant analysis from next generation sequencing data.
    Xu J; Xu W; Briollais L
    Biometrics; 2021 Mar; 77(1):316-328. PubMed ID: 32277476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.
    Larson NB; McDonnell S; Albright LC; Teerlink C; Stanford J; Ostrander EA; Isaacs WB; Xu J; Cooney KA; Lange E; Schleutker J; Carpten JD; Powell I; Bailey-Wilson J; Cussenot O; Cancel-Tassin G; Giles G; MacInnis R; Maier C; Whittemore AS; Hsieh CL; Wiklund F; Catalona WJ; Foulkes W; Mandal D; Eeles R; Kote-Jarai Z; Ackerman MJ; Olson TM; Klein CJ; Thibodeau SN; Schaid DJ
    Genet Epidemiol; 2016 Sep; 40(6):461-9. PubMed ID: 27312771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.
    Lee S; Emond MJ; Bamshad MJ; Barnes KC; Rieder MJ; Nickerson DA; ; Christiani DC; Wurfel MM; Lin X
    Am J Hum Genet; 2012 Aug; 91(2):224-37. PubMed ID: 22863193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical Bayesian model for rare variant association analysis integrating genotype uncertainty in human sequence data.
    He L; Pitkäniemi J; Sarin AP; Salomaa V; Sillanpää MJ; Ripatti S
    Genet Epidemiol; 2015 Feb; 39(2):89-100. PubMed ID: 25395270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On Robust Association Testing for Quantitative Traits and Rare Variants.
    Wei P; Cao Y; Zhang Y; Xu Z; Kwak IY; Boerwinkle E; Pan W
    G3 (Bethesda); 2016 Dec; 6(12):3941-3950. PubMed ID: 27678522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imputation-based assessment of next generation rare exome variant arrays.
    Martin AR; Tse G; Bustamante CD; Kenny EE
    Pac Symp Biocomput; 2014; ():241-52. PubMed ID: 24297551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal tests for rare variant effects in sequencing association studies.
    Lee S; Wu MC; Lin X
    Biostatistics; 2012 Sep; 13(4):762-75. PubMed ID: 22699862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real world scenarios in rare variant association analysis: the impact of imbalance and sample size on the power in silico.
    Zhang X; Basile AO; Pendergrass SA; Ritchie MD
    BMC Bioinformatics; 2019 Jan; 20(1):46. PubMed ID: 30669967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel bayes factors that capture expert uncertainty in prior density specification in genetic association studies.
    Spencer AV; Cox A; Lin WY; Easton DF; Michailidou K; Walters K
    Genet Epidemiol; 2015 May; 39(4):239-48. PubMed ID: 25727067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNP calling by sequencing pooled samples.
    Raineri E; Ferretti L; Esteve-Codina A; Nevado B; Heath S; Pérez-Enciso M
    BMC Bioinformatics; 2012 Sep; 13():239. PubMed ID: 22992255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of globally obtained informative priors on bayesian safety performance functions developed for Australian crash data.
    Afghari AP; Haque MM; Washington S; Smyth T
    Accid Anal Prev; 2019 Aug; 129():55-65. PubMed ID: 31108237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayes factor in one-sample tests of means with a sensitivity analysis: A discussion of separate prior distributions.
    Du H; Edwards MC; Zhang Z
    Behav Res Methods; 2019 Oct; 51(5):1998-2021. PubMed ID: 31161425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of statistical methods for DNA methylation microarray data analysis.
    Li D; Xie Z; Pape ML; Dye T
    BMC Bioinformatics; 2015 Jul; 16():217. PubMed ID: 26156501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and optimal design for association studies using next-generation sequencing with case-control pools.
    Liang WE; Thomas DC; Conti DV
    Genet Epidemiol; 2012 Dec; 36(8):870-81. PubMed ID: 22972696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast and noise-resilient approach to detect rare-variant associations with deep sequencing data for complex disorders.
    Cheung YH; Wang G; Leal SM; Wang S
    Genet Epidemiol; 2012 Nov; 36(7):675-85. PubMed ID: 22865616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimal test with maximum average power while controlling FDR with application to RNA-seq data.
    Si Y; Liu P
    Biometrics; 2013 Sep; 69(3):594-605. PubMed ID: 23889143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond Rare-Variant Association Testing: Pinpointing Rare Causal Variants in Case-Control Sequencing Study.
    Lin WY
    Sci Rep; 2016 Feb; 6():21824. PubMed ID: 26903168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical Bayes scan statistics for detecting clusters of disease risk variants in genetic studies.
    McCallum KJ; Ionita-Laza I
    Biometrics; 2015 Dec; 71(4):1111-20. PubMed ID: 26033425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Variants Association Analysis in Large-Scale Sequencing Studies at the Single Locus Level.
    Jeng XJ; Daye ZJ; Lu W; Tzeng JY
    PLoS Comput Biol; 2016 Jun; 12(6):e1004993. PubMed ID: 27355347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosting Gene Mapping Power and Efficiency with Efficient Exact Variance Component Tests of Single Nucleotide Polymorphism Sets.
    Zhou JJ; Hu T; Qiao D; Cho MH; Zhou H
    Genetics; 2016 Nov; 204(3):921-931. PubMed ID: 27646141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.